Advertisement

Accelerated Brain Aging in Adults with Major Depressive Disorder Predicts Poorer Outcome with Sertraline: Findings from the EMBARC Study

Published:September 27, 2022DOI:https://doi.org/10.1016/j.bpsc.2022.09.006

      Abstract

      Background

      Major depressive disorder (MDD) may be associated with accelerated brain aging (higher brain age than chronological age). This report evaluated whether brain age is a clinically useful biomarker by checking its test-retest reliability using magnetic resonance imaging (MRI) scans acquired one week apart and by evaluating the association of accelerated brain aging with symptom severity and antidepressant treatment outcomes.

      Methods

      Brain age was estimated in participants of Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care (EMBARC) study using T1-weighted structural MRI [MDD N=290; female N=192; healthy control (HC) N=39; female N=24]. Intraclass correlation coefficient (ICC) were used for baseline-to-week-1 test-retest reliability. Association of baseline Δ brain age (brain age minus chronological age) with Hamilton Depression Rating Scale (HAMD-17) and Concise Health Risk Tracking Self-Report (CHRT-SR) domains [impulsivity, suicide propensity (measures pessimism, helplessness, perceived lack of social support, and despair), and suicidal thoughts] were assessed at baseline (linear regression) and during 8-week-long treatment with either sertraline or placebo (repeated-measures mixed models).

      Results

      Mean (±standard deviation) baseline chronological age, brain age, and Δ brain age were 37.1±13.3, 40.6±13.1, and 3.1±6.1 years in MDD and 37.1±14.7, 38.4±12.9, and 0.6±5.5 years in HC groups, respectively. Test-retest reliability was high (ICC=0.98-1.00). Higher baseline Δ brain age in MDD group was associated with higher baseline impulsivity and suicide propensity, and predicted smaller baseline-to-week-8 reductions in HAMD-17, impulsivity, and suicide propensity with sertraline but not with placebo.

      Conclusion

      Brain age is a reliable and potentially clinically useful biomarker that can prognosticate antidepressant treatment outcomes.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Hasin D.S.
        • Sarvet A.L.
        • Meyers J.L.
        • Saha T.D.
        • Ruan W.J.
        • Stohl M.
        • et al.
        Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States.
        JAMA Psychiatry. 2018; 75: 336-346
        • Vos T.
        • Abajobir A.A.
        • Abate K.H.
        • Abbafati C.
        • Abbas K.M.
        • Abd-Allah F.
        • et al.
        Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.
        The Lancet. 2017; 390: 1211-1259
        • Schmaal L.
        • Hibar D.P.
        • Sämann P.G.
        • Hall G.B.
        • Baune B.T.
        • Jahanshad N.
        • et al.
        Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group.
        Molecular Psychiatry. 2017; 22: 900-909
        • Schmaal L.
        • Veltman D.J.
        • van Erp T.G.M.
        • Sämann P.G.
        • Frodl T.
        • Jahanshad N.
        • et al.
        Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group.
        Molecular Psychiatry. 2016; 21: 806-812
        • Dunlop K.
        • Victoria L.W.
        • Downar J.
        • Gunning F.M.
        • Liston C.
        Accelerated brain aging predicts impulsivity and symptom severity in depression.
        Neuropsychopharmacology. 2021; 46: 911-919
        • Han L.K.M.
        • Dinga R.
        • Hahn T.
        • Ching C.R.K.
        • Eyler L.T.
        • Aftanas L.
        • et al.
        Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group.
        Mol Psychiatry. 2020;
        • Ballester P.L.
        • Romano M.T.
        • de Azevedo Cardoso T.
        • Hassel S.
        • Strother S.C.
        • Kennedy S.H.
        • et al.
        Brain age in mood and psychotic disorders: a systematic review and meta-analysis.
        Acta Psychiatr Scand. 2021;
        • Han S.
        • Chen Y.
        • Zheng R.
        • Li S.
        • Jiang Y.
        • Wang C.
        • et al.
        The stage-specifically accelerated brain aging in never-treated first-episode patients with depression.
        Hum Brain Mapp. 2021; 42: 3656-3666
        • Han L.K.M.
        • Schnack H.G.
        • Brouwer R.M.
        • Veltman D.J.
        • van der Wee N.J.A.
        • van Tol M.J.
        • et al.
        Contributing factors to advanced brain aging in depression and anxiety disorders.
        Transl Psychiatry. 2021; 11: 402
        • Cropley V.L.
        • Tian Y.
        • Fernando K.
        • Mansour L.S.
        • Pantelis C.
        • Cocchi L.
        • et al.
        Brain-Predicted Age Associates With Psychopathology Dimensions in Youths.
        Biol Psychiatry Cogn Neurosci Neuroimaging. 2021; 6: 410-419
      1. Drobinin V, Van Gestel H, Helmick CA, Schmidt MH, Bowen CV, Uher R (2021): The developmental brain age is associated with adversity, depression, and functional outcomes among adolescents. Biol Psychiatry Cogn Neurosci Neuroimaging.

        • Ballester P.L.
        • Suh J.S.
        • Nogovitsyn N.
        • Hassel S.
        • Strother S.C.
        • Arnott S.R.
        • et al.
        Accelerated brain aging in major depressive disorder and antidepressant treatment response: A CAN-BIND report.
        Neuroimage Clin. 2021; 32102864
        • Trivedi M.H.
        • McGrath P.J.
        • Fava M.
        • Parsey R.V.
        • Kurian B.T.
        • Phillips M.L.
        • et al.
        Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design.
        J Psychiatr Res. 2016; 78: 11-23
        • Mayes T.L.
        • Kennard B.D.
        • Killian M.
        • Carmody T.
        • Grannemann B.D.
        • Rush A.J.
        • et al.
        Psychometric properties of the concise health risk tracking (CHRT) in adolescents with suicidality.
        J Affect Disord. 2018; 235: 45-51
        • Mayes T.L.
        • Killian M.
        • Rush A.J.
        • Emslie G.J.
        • Carmody T.
        • Kennard B.D.
        • et al.
        Predicting future suicidal events in adolescents using the Concise Health Risk Tracking Self-Report (CHRT-SR).
        J Psychiatr Res. 2020; 126: 19-25
        • Reilly-Harrington N.A.
        • Shelton R.C.
        • Kamali M.
        • Rabideau D.J.
        • Shesler L.W.
        • Trivedi M.H.
        • et al.
        A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-Report.
        J Affect Disord. 2016; 192: 212-218
        • Liu R.T.
        • Trout Z.M.
        • Hernandez E.M.
        • Cheek S.M.
        • Gerlus N.
        A behavioral and cognitive neuroscience perspective on impulsivity, suicide, and non-suicidal self-injury: Meta-analysis and recommendations for future research.
        Neurosci Biobehav Rev. 2017; 83: 440-450
        • Wang Y.Y.
        • Jiang N.Z.
        • Cheung E.F.
        • Sun H.W.
        • Chan R.C.
        Role of depression severity and impulsivity in the relationship between hopelessness and suicidal ideation in patients with major depressive disorder.
        J Affect Disord. 2015; 183: 83-89
        • Williams J.B.
        A structured interview guide for the Hamilton Depression Rating Scale.
        Archives of general psychiatry. 1988; 45: 742-747
      2. Hamilton M (1986): The Hamilton rating scale for depression. Assessment of depression: Springer, pp 143-152.

        • Rush A.J.
        • Trivedi M.H.
        • Ibrahim H.M.
        • Carmody T.J.
        • Arnow B.
        • Klein D.N.
        • et al.
        The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.
        Biological psychiatry. 2003; 54: 573-583
        • Vittengl J.R.
        • Clark L.A.
        • Kraft D.
        • Jarrett R.B.
        Multiple measures, methods, and moments: a factor-analytic investigation of change in depressive symptoms during acute-phase cognitive therapy for depression.
        Psychological Medicine. 2005; 35: 693-704
        • Trombello J.M.
        • Killian M.O.
        • Grannemann B.D.
        • Rush A.J.
        • Mayes T.L.
        • Parsey R.V.
        • et al.
        The Concise Health Risk Tracking-Self Report: Psychometrics within a placebo-controlled antidepressant trial among depressed outpatients.
        J Psychopharmacol. 2019; 33: 185-193
        • Jha M.K.
        • Minhajuddin A.
        • Chin Fatt C.
        • Kircanski K.
        • Stringaris A.
        • Leibenluft E.
        • et al.
        Association between irritability and suicidal ideation in three clinical trials of adults with major depressive disorder.
        Neuropsychopharmacology. 2020; 45: 2147-2154
        • Chin Fatt C.R.
        • Jha M.K.
        • Cooper C.M.
        • Fonzo G.
        • South C.
        • Grannemann B.
        • et al.
        Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression.
        Am J Psychiatry. 2020; 177: 143-154
        • Cole J.H.
        • Leech R.
        • Sharp D.J.
        Prediction of brain age suggests accelerated atrophy after traumatic brain injury.
        Ann Neurol. 2015; 77: 571-581
      3. Cole JH (2019): james-cole/brainageR: brainageR v2.1 (Version 2.1). Zenodo. .

      4. Ashburner J, Barnes G, Chen C-C, Daunizeau J, Flandin G, Friston K, et al. (2014): SPM12 manual. Wellcome Trust Centre for Neuroimaging, London, UK. 2464:4.

        • Cole J.H.
        • Poudel R.P.K.
        • Tsagkrasoulis D.
        • Caan M.W.A.
        • Steves C.
        • Spector T.D.
        • et al.
        Predicting brain age with deep learning from raw imaging data results in a reliable and heritable biomarker.
        Neuroimage. 2017; 163: 115-124
      5. Karatzoglou A, Smola A, Hornik K, Karatzoglou MA (2019): Package ‘kernlab’. CRAN R Project.

        • Taylor J.R.
        • Williams N.
        • Cusack R.
        • Auer T.
        • Shafto M.A.
        • Dixon M.
        • et al.
        The Cambridge Centre for Ageing and Neuroscience (Cam-CAN) data repository: Structural and functional MRI, MEG, and cognitive data from a cross-sectional adult lifespan sample.
        neuroimage. 2017; 144: 262-269
        • Van Essen D.C.
        • Smith S.M.
        • Barch D.M.
        • Behrens T.E.
        • Yacoub E.
        • Ugurbil K.
        The WU-Minn Human Connectome Project: an overview.
        Neuroimage. 2013; 80: 62-79
        • Chin Fatt C.R.
        • Jha M.K.
        • Minhajuddin A.
        • Mayes T.
        • Trivedi M.H.
        Sex-specific differences in the association between body mass index and brain aging in young adults: Findings from the human connectome project.
        Psychoneuroendocrinology. 2021; 124105059
        • Maclaren J.
        • Han Z.
        • Vos S.B.
        • Fischbein N.
        • Bammer R.
        Reliability of brain volume measurements: a test-retest dataset.
        Sci Data. 2014; 1140037
        • Buimer E.E.L.
        • Pas P.
        • Brouwer R.M.
        • Froeling M.
        • Hoogduin H.
        • Leemans A.
        • et al.
        The YOUth cohort study: MRI protocol and test-retest reliability in adults.
        Dev Cogn Neurosci. 2020; 45100816
        • Trivedi M.H.
        • South C.
        • Jha M.K.
        • Rush A.J.
        • Cao J.
        • Kurian B.
        • et al.
        A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial.
        Psychother Psychosom. 2018; 87: 285-295
        • Cole J.H.
        Multimodality neuroimaging brain-age in UK biobank: relationship to biomedical, lifestyle, and cognitive factors.
        Neurobiol Aging. 2020; 92: 34-42
        • Kolbeinsson A.
        • Filippi S.
        • Panagakis Y.
        • Matthews P.M.
        • Elliott P.
        • Dehghan A.
        • et al.
        Accelerated MRI-predicted brain ageing and its associations with cardiometabolic and brain disorders.
        Sci Rep. 2020; 1019940
        • de Lange A.G.
        • Anatürk M.
        • Suri S.
        • Kaufmann T.
        • Cole J.H.
        • Griffanti L.
        • et al.
        Multimodal brain-age prediction and cardiovascular risk: The Whitehall II MRI sub-study.
        Neuroimage. 2020; 222117292
        • Cole J.H.
        • Ritchie S.J.
        • Bastin M.E.
        • Valdés Hernández M.C.
        • Muñoz Maniega S.
        • Royle N.
        • et al.
        Brain age predicts mortality.
        Mol Psychiatry. 2018; 23: 1385-1392
        • Paixao L.
        • Sikka P.
        • Sun H.
        • Jain A.
        • Hogan J.
        • Thomas R.
        • et al.
        Excess brain age in the sleep electroencephalogram predicts reduced life expectancy.
        Neurobiol Aging. 2020; 88: 150-155
        • Trivedi M.H.
        • Chin Fatt C.R.
        • Jha M.K.
        • Cooper C.M.
        • Trombello J.M.
        • Mason B.L.
        • et al.
        Comprehensive phenotyping of depression disease trajectory and risk: Rationale and design of Texas Resilience Against Depression study (T-RAD).
        J Psychiatr Res. 2020; 122: 22-32
        • Zimmerman M.
        • Balling C.
        • Chelminski I.
        • Dalrymple K.
        Have Treatment Studies of Depression Become Even Less Generalizable? Applying the Inclusion and Exclusion Criteria in Placebo-Controlled Antidepressant Efficacy Trials Published over 20 Years to a Clinical Sample.
        Psychother Psychosom. 2019; 88: 165-170
        • Fortin J.P.
        • Parker D.
        • Tunç B.
        • Watanabe T.
        • Elliott M.A.
        • Ruparel K.
        • et al.
        Harmonization of multi-site diffusion tensor imaging data.
        Neuroimage. 2017; 161: 149-170
        • Fortin J.P.
        • Cullen N.
        • Sheline Y.I.
        • Taylor W.D.
        • Aselcioglu I.
        • Cook P.A.
        • et al.
        Harmonization of cortical thickness measurements across scanners and sites.
        Neuroimage. 2018; 167: 104-120
        • Keding T.J.
        • Heyn S.A.
        • Russell J.D.
        • Zhu X.
        • Cisler J.
        • McLaughlin K.A.
        • et al.
        Differential Patterns of Delayed Emotion Circuit Maturation in Abused Girls With and Without Internalizing Psychopathology.
        Am J Psychiatry. 2021; 178: 1026-1036